Skip to main content
Toggle navigation
Login
Home
Session Icons
Special Event
Livestream / Recorded
Multiple Session Occurences
Audience Response System
Ticketed Session
Presentado en Espanol
Closed Captioning
Scientific Program
Sold Out Ticketed Session
New & Evolving Topics
Traduccion Espanol
Rx (Pharmacology)
Poster Icons
Oral Presentations
Poster Presentations
Back
Favorite
Michael Højby, MD PhD
International Medical Vice President
Novo Nordisk, Denmark
Abstract(s):
P4.A013: Sustained Efficacy of Weekly Somapacitan in Children With GHD: 3-year Results From Phase 3 REAL4 Study
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT
P4.A016: Weekly Somapacitan in Children with Growth Hormone Deficiency: Subgroup Analysis Results of the REAL4 Randomized Phase 3 Trial by Baseline Growth Hormone Peak Concentration
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT